'Grass Is Greener' For Zynerba Pharma: Buy The Stock, Says Canaccord

By: via Benzinga
In a report issued Monday, Canaccord analysts Corey Davis and Lidia Liu initiated coverage on shares of Zynerba Pharmaceuticals Inc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.